Sarepta Therapeutics Inc (SRPT)

Exchange
NASDAQ
Symbol
SRPT
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapies, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company is headquartered in Cambridge, Massachusetts.
Country
USA

Stock price

At close: July 18, 2025

  • Open
    16.98
  • High
    19.18
  • Low
    12.81
  • Close
    14.08
  • Volume
    78,437,700

Financial ratios

Dec 31, 2024